A Prospective Randomized Clinical Trial for Measuring Radiology Study
  Reporting Time on Artificial Intelligence-Based Detection of Intracranial
  Hemorrhage in Emergent Care Head CT by Wismüller, Axel & Stockmaster, Larry
 
 
This is a pre-print version of a publication that was presented at the  
SPIE Medical Imaging 2020 Conference, Houston, TX, February 15-20, 2020. 
 
 
A Prospective Randomized Clinical Trial for Measuring Radiology 
Study Reporting Time on Artificial Intelligence-Based Detection of 
Intracranial Hemorrhage in Emergent Care Head CT 
 
Axel Wismüller1,2,3,4 and Larry Stockmaster1 
1Department of Imaging Sciences, University of Rochester Medical Center, Rochester, NY, USA 
2Department of Biomedical Engineering, University of Rochester, NY, USA 
3Department of Electrical Engineering, University of Rochester, NY, USA 
4Faculty of Medicine and Institute of Clinical Radiology, Ludwig Maximilian University, Munich, Germany 
 
ABSTRACT 
The quantitative evaluation of Artificial Intelligence (AI) systems in a clinical context is a challenging endeavor, where 
the development and implementation of meaningful performance metrics is still in its infancy. Here, we propose a 
scientific concept, Artificial Intelligence Prospective Randomized Observer Blinding Evaluation (AI-PROBE) for 
quantitative clinical performance evaluation of radiology AI systems within prospective randomized clinical trials. Our 
evaluation workflow encompasses a study design and a corresponding radiology Information Technology (IT) 
infrastructure that randomly blinds radiologists with regards to the presence of positive reads as provided by AI-based 
image analysis systems. To demonstrate the applicability of our AI-evaluation framework, we present a first prospective 
randomized clinical trial on investigating the effect of automatic identification of Intra-Cranial Hemorrhage (ICH) in 
emergent care head CT scans on radiology study Turn-Around Time (TAT) in a clinical environment. Here, we acquired 
620 consecutive non-contrast head CT scans from CT scanners used for inpatient and emergency room patients at a large 
academic hospital over a time period of 14 consecutive days. Immediately following image acquisition, scans were 
automatically analyzed for the presence of ICH using commercially available software (Aidoc, Tel Aviv, Israel). Cases 
identified as positive for ICH by AI (ICH-AI+) were automatically flagged in the radiologists' reading worklists, where 
flagging was randomly switched off with a probability of 50%. Study TAT was measured automatically as the time 
difference between study completion and first clinically communicated study reporting, with time stamps for these 
events automatically retrieved from various radiology IT systems. TATs for flagged cases (73 ± 143 min) were 
significantly lower than TATs for non-flagged (132 ± 193 min) cases (p<0.05, one-sided t-test), where 105 of the 122 
ICH-AI+ cases were true positive reads. Total sensitivity, specificity, and accuracy over all analyzed cases were 95.0%, 
96.7%, and 96.4%, respectively. We conclude that automatic identification of ICH reduces study TAT for ICH in 
emergent care head CT settings, which carries the potential for improving clinical management of ICH by accelerating 
clinically indicated therapeutic interventions. In a broader context, our results suggest that our AI-PROBE framework 
can contribute to a systematic quantitative evaluation of AI systems in a clinical workflow environment with regards to 
clinically meaningful performance measures, such as TAT or diagnostic accuracy metrics. 
 
Keywords: Artificial intelligence, intracranial hemorrhage, radiology turn-around time, prospective randomized 
observer blinding evaluation 
1. INTRODUCTION 
A key challenge for the adoption of Artificial Intelligence (AI) systems in a clinical context is the generic lack of 
standards for objectively evaluating such systems with regards to clinically meaningful performance metrics. Solely 
relying on classical performance metrics from machine learning or signal processing, such as Receiver Operating 
Characteristic (ROC) analysis of diagnostic accuracy or computation times, may be helpful for initially evaluating and 
comparing AI systems on benchmark data in isolation from their actual clinical application context, but they fall short at 
evaluating the clinical usefulness of AI systems in real-world settings. 
A fully automated diagnosis by AI systems without human intervention would potentially require a ‘strong’ artificial 
intelligence to be socially acceptable. As artificial intelligence, despite its 70-year history, is still in its infancy, the 
deployment and operation of AI systems in medicine will continue to require human control and supervision in the 
foreseeable future. Hence, an objective evaluation of contemporary AI systems can only be based on the interplay of 
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such systems with human experts using them in a real-world context, such as radiologists in a clinical reading workflow 
environment. Here, it is important to understand that not only the performance of the ‘inference machine’ in AI systems, 
such as their classification or regression quality, determines their real-world usefulness, but that other factors, such as 
user interface, ease of access, user motivation, etc., may play a critical role as well. 
Although most of the academic literature on AI in medical imaging focuses on comparing the performance of different 
AI systems on given data, such as in various ‘competitions’ on publicly available benchmark data, see e.g. [1], [2], [3], it 
is often more important to investigate the effects of deployment of a single AI system based on quantitative measurable 
clinical parameters. The reason for this is that AI systems, such as other capital investments in the healthcare enterprise, 
are usually not introduced in a clinical workflow environment for the sake of comparing them to each other. Rather a 
decision is made for deploying a single system in a given environment, based on administrative, financial or business 
development considerations. In radiology, for example, the challenge of evaluating the clinical usefulness of an AI 
system would be to compare the radiologists’ performance with and without using the system, where clinically 
meaningful performance measures are determined, such as diagnostic accuracy or study turnaround time, resulting from 
human-machine inter-operability. 
To address this challenge, we propose a scientific framework, Artificial Intelligence Prospective Randomized Observer 
Blinding Evaluation (AI-PROBE) for quantitative clinical performance evaluation of radiology AI systems within 
prospective randomized clinical trials. Our evaluation workflow encompasses a study design and a corresponding 
radiology Information Technology (IT) infrastructure that randomly blinds radiologists with regards to the presence of 
positive reads as provided by AI-based image analysis systems.  
In the following, we will explain the basic idea of AI-PROBE, describe its clinical application within a prospective 
randomized clinical trial for AI-based detection of ICH in emergent care head CT scans, and will report study results on 
radiology turnaround times for this clinical application. This work is embedded in our group’s endeavor to expedite 
artificial intelligence in biomedical imaging by means of advanced pattern recognition and machine learning methods for 
computational radiology and radiomics, e.g. [4–54]. 
2. SCIENTIFIC CONCEPT 
2.1 Shortcomings of Retrospective AI evaluation 
The potential of retrospective performance analysis of radiology AI systems is limited and subject to manifold 
systematic errors. A typical scenario for retrospective analysis would be to compare certain clinical outcome measures 
before and after deployment of an AI system into a radiology workflow. Such systematic errors include temporal 
changes before and after AI deployment, such as changing radiology staffing, work organization patterns, or temporal 
shifts of case distributions, to name a few. In order to avoid such systematic errors, it follows that retrospective AI 
evaluation approaches, although widely used, should be replaced by prospective evaluation methods. However, 
introducing prospective radiology AI evaluation is challenging, because (i) there is limited experience and literature on 
prospective approaches to radiology AI system evaluation, (ii) such approaches imply significant both organizational and 
technical efforts. 
2.2 Artificial Intelligence Prospective Randomized Observer Blinding Evaluation (AI-PROBE) 
To address this challenge, we propose a scientific concept, Artificial Intelligence Prospective Randomized Observer 
Blinding Evaluation (AI-PROBE), for quantitative clinical performance evaluation of radiology AI systems within 
prospective randomized clinical trials. Our evaluation workflow encompasses a study design that randomly blinds 
radiologists with regards to the presence of reading results provided by AI-based image analysis systems. There are 
various options within this concept, which can be chosen according to the clinical needs of a specific evaluation 
situation.  
(i) The first option, AI-PROBE-1, is specifically suited for radiology worklist prioritization, where radiologists may only 
be interested to be informed about positive reads, for example, flagging of cases, in which an AI system has identified an 
emergent finding, such as an intracranial hemorrhage on a head CT scan. In this scenario, having no flag associated with 
a radiology study does not provide any information to the observer, as to whether she was blinded about the AI reading 
results based on the AI-PROBE clinical trial design, whether the study was analyzed at all, or whether it was analyzed, 
but has been rated by the AI system as a negative read for the examined condition. 
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(ii) The second option, AI-PROBE-2, randomly blinds the observer about the results of AI system reads, but flags all 
cases that have been analyzed by the AI system. In this scenario, different types of flags need to be utilized. In the 
simplest case, the user would have to be informed, whether a case was read as positive or negative by the AI system for 
an examined condition, such as for the presence or absence of an intracranial hemorrhage. Having no flag associated 
with a given radiology study informs the user that there are no AI reading results available for this case for any reason, 
be it that the user was blinded for the given case according to the AI-PROBE clinical trial design, or that there are no AI 
reading results available for any technical reasons. Such technical reasons can be manifold, including (i) that a given 
scanner or imaging archive was not connected to the AI system, (ii) the case was not sent for analysis, (iii) the case was 
sent, but not analyzed, (iv) the case was analyzed, but no results are available, such as induced by network 
communication or inference machine processing delays. Note that this list of reasons is not exhaustive, and that an 
arbitrary number of additional flags may be introduced to inform the user about such reasons. 
A free parameter that needs to be considered is the probability P for selecting cases, for which radiologists will be 
blinded with regards to AI reading results. For simplicity, in the trial on intracranial hemorrhage reported below, we 
chose an AI-PROBE-1 study design with P=50%. 
We emphasize that multiple organizational and technical challenges have to be met simultaneously for implementing an 
AI-PROBE study design. These challenges include, but are not limited to, (i) acquiring Institutional Review Board 
approval for radiologists’ participation in such prospective trials, (ii) aligning the interests of diverse stakeholders, 
including radiologists, hospital administrators, and AI solution vendors, and (iii) significant interface programming 
efforts for automatically retrieving heterogeneous information from multiple radiology and hospital IT systems, such as 
various time stamps for events related to technical processing or human intervention. 
3. CLINICAL APPLICATION: INTRACRANIAL HEMORRHAGE DETECTION TRIAL 
Clinical Relevance: To demonstrate the applicability of our AI-evaluation framework, we present a first prospective 
randomized trial on investigating the effect of automatic identification of Intra-Cranial Hemorrhage (ICH) in emergent 
care head CT scans on radiology study Turn-Around Time (TAT) in a clinical environment. Timely detection of ICH on 
medical imaging studies is critical, because delayed therapeutic interventions in emergency settings may be detrimental 
for patient outcome. For example, in hemorrhagic stroke, the American Heart Association (AHA)/American Stroke 
Association (ASA) 2018 guidelines for early management emphasize the time-dependent benefit of tissue plasminogen 
activator (tPA) therapy [55]. Patients with ischemic stroke must be identified as soon as possible so that tPA can be 
administered within 3-4.5 hours of symptom onset [55]. A non-contrast head CT scan, which must be negative for 
hemorrhage, is a required diagnostic test before tPA can be administered in a timely manner [56,57,58]. The clinical 
outcomes of patients receiving tPA within a designated time limit are closely linked to time of treatment [58,59]. Besides 
hemorrhagic stroke, there are numerous other clinical conditions, in which ICH will lead to rapid increase of intracranial 
pressure, where early detection and treatment of ICH can significantly reduce patient morbidity and mortality.  
Data and Methods: A total of 620 consecutive non-contrast head CT scans from two CT scanners used for inpatient and 
Figure 1: Box and whiskers plots for 
study turnaround times for flagged and 
non-flagged CT cases identified as 
positive for intracranial hemorrhage by a 
commercial image analysis system. Note 
that non-flagged cases appear to have a 
higher turnaround time (one-sided t-test) 
with means of 73 min for flagged cases, 
and 132 min for non-flagged cases. 
Horizontal lines represent the 25th, 50th, 
and 75th percentiles, respectively. For 
details, see text.   
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emergency room patients at a large academic hospital (Strong Memorial Hospital, University of Rochester Medical 
Center) were prospectively acquired over a time period of 14 consecutive days. Immediately following image 
acquisition, scans were automatically analyzed for the presence of intracranial hemorrhage (ICH) using commercially 
available software (Aidoc, Tel Aviv, Israel). Cases identified as positive for ICH by AI (ICH-AI+) were automatically 
flagged in the radiologists' reading worklists, where flagging was randomly switched off with a probability P=50%. 
Study turnaround time (TAT) was measured automatically as the time difference between study completion time (=study 
accessible to radiologists for reporting) to study reporting time (=first report visible to clinicians, regardless whether 
preliminary or final). Time stamps for calculating TAT were automatically retrieved from various radiology IT systems. 
The hypothesis that TATs for non-flagged ICH-AI+ cases were higher than for flagged ICH-AI+ cases was tested using 
a one-sided heteroscedastic t-test. Total sensitivity, specificity, and accuracy for ICH detection were calculated for all 
analyzed 620 cases, where final radiology reports served as ground truth. 
4. RESULTS 
A total of 122 ICH-AI+ cases were found among the total number of analyzed 620 non-contrast head CT cases, of which 
66 cases were flagged. Study TAT was measured automatically as the time difference between study completion time, 
i.e., when the study became accessible to radiologists for reporting, and the study reporting time, i.e., when the first 
report was completed that was visible to clinicians, regardless whether this report legally qualified as a preliminary or as 
a final report. Figure 1 summarizes our results on the distributions of radiology study turnaround times (TAT), 
comparing flagged and non-flagged ICH-AI+ cases. It can be seen that the TAT distributions for flagged and non-
flagged cases are different, with higher TATs observed for non-flagged ICH-AI+ cases. This is confirmed by statistical 
analysis: TATs for flagged cases (73 ± 143 min) were significantly lower than TATs for non-flagged (132 ± 193 min) 
cases (p<0.05, one-sided t-test). A total of 105 of the 122 ICH-AI+ cases were true positive reads, as verified by human 
review of final radiology reports. Total sensitivity, specificity, and accuracy over all analyzed 620 cases were 95.0%, 
96.7%, and 96.4%, respectively. 
5. NEW AND BREAKTHROUGH WORK 
We introduce a scientific framework, Artificial Intelligence Prospective Randomized Observer Blinding Evaluation (AI-
PROBE) for quantitative clinical performance evaluation of radiology AI systems within prospective randomized clinical 
trials. Our evaluation workflow encompasses a study design and a corresponding radiology information technology 
infrastructure that randomly blinds radiologists with regards to the presence of positive reads as provided by AI-based 
image analysis systems. To demonstrate the applicability of our AI-evaluation framework, we present a first prospective 
randomized clinical trial on investigating the effect of automatic identification of Intra-Cranial Hemorrhage (ICH) in 620 
emergent care head CT scans on radiology study Turn-Around Time (TAT) in a clinical environment. Our results 
suggest that notifying radiologists on automatically detected ICH reduces TAT for reporting ICH to clinicians in 
emergency setting head CT scans, as shown by our prospective, randomized clinical study. Such reduced TAT may 
expedite clinically indicated therapeutic interventions. 
6. CONCLUSION 
We conclude from our prospective randomized clinical trial that automatic identification of Intra-Cranial Hemorrhage 
(ICH) reduces radiology study turnaround times for ICH in emergent care head CT settings, which carries the potential 
for improving clinical management of ICH by accelerating clinically indicated therapeutic interventions. In a broader 
scientific context, our results suggest that the proposed AI-PROBE framework can contribute to a systematic quantitative 
evaluation of AI systems in a real-world workflow environment with regards to clinically meaningful performance 
metrics, such as radiology study turnaround times or diagnostic accuracy measures. 
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